About the Company
We do not have any company description for BiomX Inc. at the moment.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on BiomX Inc.
BiomX Inc. (AMEX:PHGE) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 13, 2025 BiomX Inc. beats earnings expectations. Reported EPS is $-0.19, expectations ...
BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis
U.S. FDA has placed a clinical hold on the Phase 2b study as it reviews data submitted by BiomX on third-party nebulizer used ...
BiomX Inc. Reports Q2 2025 Progress and Financials
Biomx Inc. ( ($PHGE) ) has released its Q2 earnings. Here is a breakdown of the information Biomx Inc. presented to its investors. BiomX Inc., a ...
BiomX Inc. Secures $12 Million in Financing to Advance ... - Nasdaq
BiomX Inc. announced in March 2025 that it secured approximately $12 million in financing to facilitate the completion of its Phase 2b trial for BX004, with topline results expected in Q1 2026.
BiomX Inc. (PHGEW) - Yahoo Finance
CAMBRIDGE, Mass. and NESS ZIONA, Israel, Nov. 30, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and ...
BiomX Inc. to Present Positive Phase 2 Results for BX211 at ... - Nasdaq
BiomX Inc., a clinical-stage company specializing in phage therapies for bacterial infections, announced that CEO Jonathan Solomon will present the company's promising Phase 2 trial results for ...
BiomX Inc.
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in ...
BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing ...
BiomX, Inc. Assaf Oron +97254-2228901 assafo@biomx.com NOTE: This content is not written by or endorsed by "KXAN", its advertisers, or Nexstar Media Inc.
BiomX Inc. (NYSEMKT:PHGE): Looks Promising | Seeking Alpha
BiomX Inc. BiomX, formerly Chardan Healthcare Acquisition Corp. ("CHAC"), was originally incorporated in Delaware on November 1, 2017. On July 16, 2019 CHAC entered into an agreement to merge with ...
Why BiomX Stock Is Surging Today - BiomX (AMEX:PHGE)
BiomX shares are trading higher Wednesday after the company announced it has entered into a definitive merger agreement with Adaptive Phage Therapeutics, Inc. The acquisition is expected to close ...
BiomX Inc: BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis
U.S. FDA has placed a clinical hold on the Phase 2b study as it reviews data submitted by BiomX on third-party nebulizer used to deliver BX004; no concerns were raised in the clinical hold notificatio ...
BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing ...
BiomX, Inc. Assaf Oron +97254-2228901 assafo@biomx.com Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post.
Similar Companies
Loading the latest forecasts...